# Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

> **NCT03683680** · NA · RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 240 (estimated)

## Conditions studied

- Mesothelioma

## Interventions

- **OTHER:** MPT Test
- **OTHER:** CLDN15/VIM Test

## Key facts

- **NCT ID:** NCT03683680
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-10-31
- **Primary completion:** 2030-01-01
- **Final completion:** 2030-10-01
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03683680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03683680, "Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03683680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*